Mucormycosis and COVID-19 coinfection in kidney transplant recipient

Abstract

In the current pandemic of COVID-19, kidney transplant recipients with COVID-19 are at an additional risk of contracting mucormycosis and other infections. Rarely, coinfection of COVID-19 and mucormycosis in kidney transplant recipient may occur, which poses challenges in the management. Mucormycosis is caused by a fungus of Mucorales family. Delayed identification and management are associated with a higher mortality. High index of suspicion is needed for timely interventions. We report a case of COVID-19 coinfection with mucormycosis in a kidney transplant recipient. Timely treatment with antifungal drugs like liposomal amphotericin B with surgical debridement helped cure the patient and prevent damage to the brain.

Keywords

• coinfection
• covid-19
• immunocompromised
• kidney transplant recipient
• liposomal amphotericin b
• mucormycosis